Form 4: Evolent Health Director Mary Bridget Duffy Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Mary Bridget Duffy, a director at Evolent Health, reported the acquisition of restricted stock units and a transfer of shares due to a domestic relations order.

Summary

  • On June 6, 2024, Mary Bridget Duffy, a director of Evolent Health, Inc., reported changes in her beneficial ownership of the company's Class A Common Stock.
  • She acquired 7,709 restricted stock units under the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • These securities vest on the earlier of June 6, 2025, and the date of the company's 2025 annual meeting, contingent upon her continued service.
  • Duffy also transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock due to a domestic relations order, and she no longer reports securities owned by her ex-spouse.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting changes in beneficial ownership, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in director Duffy's holdings of Evolent Health stock.

Stakeholder Impact

  • The transfer of shares due to a domestic relations order may have a minor impact on the overall shareholder base.

Key Dates

DateDescription
06/06/2024Date of transaction: acquisition of restricted stock units and transfer of shares.
06/06/2025Earliest vesting date for the restricted stock units.
06/10/2024Date of signature for the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.